Paradigm Biopharmaceuticals Ltd.ASX: PAR

All 10 participants in US FDA EAP have commenced treatment

Mar 24, 2020 at 1:42 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment